UBS ASSET MANAGEMENT AMERICAS INC - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$109,509
-22.2%
12,2220.0%0.00%
Q2 2023$140,7980.0%12,2220.0%0.00%
Q1 2023$140,798
-0.6%
12,2220.0%0.00%
Q4 2022$141,653
-99.9%
12,2220.0%0.00%
Q3 2022$155,219,000
+84.9%
12,2220.0%0.00%
Q2 2022$83,965,000
-28.7%
12,2220.0%0.00%
Q1 2022$117,820,000
-18.9%
12,2220.0%0.00%
Q4 2021$145,319,000
-26.8%
12,2220.0%0.00%
Q3 2021$198,486,00012,2220.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders